Lower riskDrug recall · FDA · Published April 9, 2025
Wegovy injection recall: Temperature abuse risk from shipping error
Cardinal Health recalls Wegovy (semaglutide) injections due to potential temperature exposure during shipping. This may cause product instability. Check your lot number and contact Novo Nordisk for details.
Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.
Take action
Contact the company
📍Recalling firmCardinal Health Inc.7000 Cardinal Pl · Dublin, OH 43017-1091
“Wegovy injection recall: Temperature abuse risk from shipping error.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32157-wegovy-injection-recall-temperature-abuse-risk-from-shipping-error. Based on FDA recall #D-0393-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0393-2025%22&limit=1).
Cardinal Health Inc. recalled Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton on April 9, 2025, according to the FDA. The product was potentially exposed to temperatures outside labeled storage conditions due to a shipping error. Distribution included North Carolina, South Carolina, and Virginia.
The Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. Specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.
Context
GovInfoNow's records show Cardinal Health Inc. has 11 other recalls on record since 2018-11-16. Other recent recalls include Enoxaparin 30mg Syringes (2025-08-05), RECOMBINATE Antihemophilic Factor (2025-07-30), and LEADER Dry Eye Relief (2023-10-31). Other recent recalls of similar products include UDENYCA Injection (2026-01-16) and Gemcitabine Injection (2026-06-10).
How to tell if you have this one
Check the lot number on the product label, which should be PZFDE06. The product is a Wegovy injection (semaglutide) 2.4 mg/0.75 mL, 4 pens per carton, manufactured by Novo Nordisk.
Brand
Cardinal Health
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Lot Number
Look for the lot number PZFDE06 on the product label to confirm if it is affected.
Contact Novo Nordisk
Reach out to Novo Nordisk for specific guidance on next steps if the product is recalled.
Where it went and when
Where it was distributed
Distributed in 3 states.
Listed by the agency
Not listed
FDA distribution: “NC, SC, VA” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: North Carolina, South Carolina, Virginia.
Recall timeline
FDA published this recall 28 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0393-2025 (April 9, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0393-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.